Yali She

Yali She


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YSYali She
Yali She
XZXiaowen Zhao
Xiaowen Zhao
PWPingfan Wu
Pingfan Wu
LXLing Xue
Ling Xue
SWShengfang Wan
Shengfang Wan
YLYaling Li
Yaling Li
Background. Gastric cancer (GC) is the fifth most common malignant tumor and the third leading cause of cancer‐related deaths. Because GC has the characteristics of high heterogeneity, unclear mechanism, limited treatment methods, and low five‐year survival rate, it is necessary to find the prognostic biomarkers of GC and explore the mechanism of GC. Methods. We first identified differentially expressed genes (DEGs) between gastric cancer and normal gastric cells through expression analysis. A protein‐protein interaction (PPI) network was constructed to find tightly connected modules. We performed survival analysis on the DEGs in the modules to identify genes with prognostic significance. Gene set enrichment analysis (GSEA) was used to identify gene enrichment pathways. Finally, we used our own collected clinical samples of 119 gastric adenocarcinoma (STAD) tissues and 40 normal gastric tissues to perform immunohistochemical (IHC) staining to verify the differential expression of COL8A1 in STAD tissues and normal gastric tissues and its correlation with epithelial‐mesenchymal transition‐ (EMT‐) related factors. Results. We identified 356 DEGs through differential expression analysis. Through PPI analysis and survival analysis, we determined that the collagen type VII alpha‐1 chain (COL8A1) gene has prognostic significance. GSEA analysis showed that COL8A1 was significantly enriched in the EMT. IHC results showed that COL8A1 was upregulated in STAD tissues and could be used as an independent prognostic factor and was related to EMT. Conclusion. This study shows that COL8A1 is related to the prognosis of GC patients and might affect the progress of GC through the EMT pathway. Therefore, COL8A1 may be a biomarker for predicting the prognosis of GC.

29 January 2025 in The American Journal of Chinese Medicine
Verified
Journal Article
Closed access
YLYaling Li
Yaling Li
XWXijia Wang
Xijia Wang
SLShuyue Li
Shuyue Li
LWLei Wang
Lei Wang
NDNingning Ding
Ningning Ding
CLChangtian Li
Changtian Li

1 August 2020 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
YLYaling Li
Yaling Li
JLJunjie Li
Junjie Li
JDJuanjuan Dong
Juanjuan Dong
LZLei Zhang
Lei Zhang
DLDongling Liu
Dongling Liu
LYLiu Yongqi
Liu Yongqi
Introduction: Host immunity plays a vital role in tumorigenesis, including in tumor invasion and metastasis. However, the precise underlying mechanism remains to be explored. The enzyme 15-PGDH, which plays a key role in prostaglandin degradation, is a critical inflammatory mediator in gastric cancer (GC) tumorigenesis. Materials and Methods: Immunohistochemistry was performed to determine 15-PGDH expression in GC and the corresponding adjacent non-neoplastic tissues (n=92). Results: The expression of 15-PGDH in GC tissues was significantly lower than that in paracancerous tissues (P< 0.001) and found to correspond inversely with GC differentiation (P= 0.043) and lymph node metastasis (P= 0.046). In contrast, FOXP3 expression was increased in poorly differentiated GC tissues (P= 0.001). Kaplan–Meier analysis revealed that GC patients with low expression of 15-PGDH (Log rank test, P= 0.007) and high expression of FOXP3 (Log rank test, P= 0.009) had shorter overall survival (OS) than those with high 15-PGDH and low FOXP3 expression. OS was also correlated with pathological tumor-node-metastasis stage (Log rank test, P= 0.014). Furthermore, using Cox proportional hazard regression, 15-PGDH expression [hazard ratio (HR): 0.605 (0.440– 0.833); P= 0.002] was identified as an independent factor for OS. Conclusion: Our data suggest that 15-PGDH may contribute to anti-tumor immunity by regulating FOXP3+ Treg cells. The findings are useful for the identification of therapeutic targets for the management of GC.

25 April 2022 in Journal of Healthcare Engineering
Verified
Journal Article
Open access
PDF file
XZXiaowen Zhao
Xiaowen Zhao
PWPingfan Wu
Pingfan Wu
DLDongling Liu
Dongling Liu
CLChangtian Li
Changtian Li
LXLing Xue
Ling Xue
YSYali She
Yali She
Background. Gastric adenocarcinoma (GAD) is one of the most common tumors in the world and the prognosis is still very poor. Objective. We sought to identify reliable prognostic biomarkers for the progression of GAD and the sensitivity to drug therapy. Method. The RNA sequencing data of GAD was downloaded from the Cancer Genome Atlas (TCGA) database and used for analysis. Differentially expressed, immune-related lncRNA (DEIRlncRNA) was characterized by differential analysis and correlation analysis. Univariate Cox regression analysis was used to identify DEIRlncRNA associated with prognosis. Least absolute shrinkage and selection operator (LASSO) regression analysis allowed us to determine a signature composed of eight IRlncRNAs. Based on this signature, we further performed gene set enrichment analysis (GSEA) and somatic mutation analysis to evaluate the ability of this signature to predict prognosis. Results. In total, 72 immune-related lncRNAs (DEIRlncRNAs) with prognostic value were identified. These lncRNAs were used to construct a model containing eight immune-related lncRNAs (8-IRlncRNAs). Based on this risk model, we divided GAD patients into high-risk and low-risk groups. The analysis showed that the prognosis of the two groups was different and that the high-risk group had worse overall survival (OS). Immune cell infiltration analysis showed that the proportion of memory B cells increased in the high-risk group while the proportion of macrophages M1, T cells, CD4 memory-activated cells, and T cell follicular helpers decreased. GSEA results showed that 8-IRlncRNA was significantly enriched in tumorigenesis pathways such as myc. The results of somatic mutation analysis showed that the CDH1 gene was significantly mutated in the high-risk group. Conclusion. A prognostic signature of 8-IRlncRNAs in GAD was established and this signature was able to predict the prognosis of GAD patients.